Dr Louise Jopling
Commercial Director, Health Innovation East
Louise holds a PhD in immunology from Imperial College London. Drawing on both her background in science and years of experience in drug discovery, development and commercialisation within academia, biotech and pharmaceutical organisations, she leads the commercial team at Health Innovation East to develop partnerships and support innovators to refine their business models and value propositions to ensure commercial sustainability.
Louise joined Health Innovation East from Johnson and Johnson Innovation, where she led partnership activities across Europe, Middle East and Africa to identify and incubate external assets and capabilities to advance the portfolio of the Immunology Therapy Area for Janssen.
Louise is a Strategic Advisor to Enhanc3D Genomics and a mentor on a number of accelerator programmes including Start Codon.
